Spheroids obtained for CSC isolation were characterized for the expression of tumor-specific CSC markers CD44+ / CD24−/low for breast CSCs, and CD133+/CD44+ for prostate and ovarian CSCs (Table 1), by using flow cytometry. This evidence concerns the gene PROM1 and neoplasm.